The critical role of IL-15 in the antitumor effects mediated by the combination therapy imatinib and IL-2. [electronic resource]
Producer: 20080619Description: 6477-83 p. digitalISSN:- 0022-1767
- Animals
- Antineoplastic Combined Chemotherapy Protocols -- pharmacology
- Benzamides
- Chemokine CCL2 -- metabolism
- Dendritic Cells -- immunology
- Flow Cytometry
- Humans
- Imatinib Mesylate
- Interleukin-15 -- immunology
- Interleukin-2 -- administration & dosage
- Killer Cells, Natural -- immunology
- Mice
- Mice, Mutant Strains
- Neoplasms, Experimental -- drug therapy
- Piperazines -- administration & dosage
- Pyrimidines -- administration & dosage
- Receptors, CCR2 -- metabolism
- Receptors, Interferon -- immunology
- Interferon gamma Receptor
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.